| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 224.50 | 3.4% | 10.5% |
| Total Income | 224.50 | 3.4% | 10.5% |
| Expenditure | 214.86 | 2.5% | 13.8% |
| PBT | 13.55 | 681.5% | 33.4% |
| Net Profit | 9.93 | 376.6% | 46.3% |
| OPM | 4.30% | 5.82pp | 2.75pp |
| NPM | 4.42% | 6.08pp | 4.68pp |
| EPS | 0.34 | 383.3% | 45.2% |
Inspire Medical Systems Reports Q3 2025 Results
04 May 2026 · 4 May, 8:19 am
Summary
Inspire Medical Systems, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2025. The press release is included as an exhibit to the 8-K filing. The company will be participating in investor and analyst meetings in November and December 2025.
Key Highlights
- 1
Inspire Medical Systems, Inc. announced its financial results for the quarter ended September 30, 2025.
- 2
The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Informational and educational content only. Not investment advice.